Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 30
Filter
1.
Animal ; 18(6): 101195, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38850574

ABSTRACT

Biochar, which is the product of biomass pyrolysis, has been suggested as a feed supplement to improve performance in livestock systems and reduce greenhouse gas emissions. The aim of the current study was to investigate in vitro and in vivo potential of biochar to favourably modify rumen fermentation (e.g., an increase in total Short Chained Fatty Acid (SCFA) concentration and a change in SCFA profile), reduce methane emission and increase sheep growth performance. Four concentrates were produced with biochar inclusion of 0, 10, 23 and 46 g/kg DM. The experimental diets for the in vitro experiments consisted of straw and concentrate in a 60:40 ratio and included measurements of total gas and methane (CH4) production, pH, ammonia nitrogen, SCFA, and microbial assays (total bacteria and methanogenic archaea). Two in vivo experiments were performed where the animals received ad libitum forage with 0.4 kg concentrate daily. Experiment 1 investigated the daily DM intake of sheep while experiment 2 investigated daily growth rate and CH4 emission of lambs. The inclusion of biochar had no impact on in vitro total gas production (ml/200 mg DM substrate) (P = 0.81) and CH4 production (ml/200 mg DM substrate) (P = 0.93). In vitro total SCFA concentration increased (P < 0.05) while acetate to propionate ratio (A:P) tended to decrease (P = 0.05) with both doses of biochar. Total bacteria decreased with the highest biochar inclusion in vitro (P < 0.05). Sheep's DM intake (kg/d) increased when low and medium levels but not when a higher level of biochar was added to the diet (P < 0.001). The inclusion of biochar did not significantly impact the lamb's daily growth rate (g/d) (P = 0.61) or enteric CH4 emissions (g/kg DM) (P = 0.43). We conclude that biochar supplementation had no favourable impacts on in vitro and in vivo CH4 production or on lamb's growth rate. Further research with well-characterised biochar is needed to gain a better understanding of the potential of biochar as a feed additive for ruminant livestock.


Subject(s)
Animal Feed , Charcoal , Diet , Fatty Acids, Volatile , Fermentation , Methane , Rumen , Animals , Methane/metabolism , Charcoal/pharmacology , Animal Feed/analysis , Rumen/microbiology , Rumen/metabolism , Fatty Acids, Volatile/metabolism , Sheep/growth & development , Diet/veterinary , Male , Eating , Dietary Supplements/analysis
2.
Appl Environ Microbiol ; 86(5)2020 02 18.
Article in English | MEDLINE | ID: mdl-31862723

ABSTRACT

Animal-associated microbes are highly variable, contributing to a diverse set of symbiont-mediated phenotypes. Given that host and symbiont genotypes, and their interactions, can impact symbiont-based phenotypes across environments, there is potential for extensive variation in fitness outcomes. Pea aphids, Acyrthosiphon pisum, host a diverse assemblage of heritable facultative symbionts (HFS) with characterized roles in host defense. Protective phenotypes have been largely studied as single infections, but pea aphids often carry multiple HFS species, and particular combinations may be enriched or depleted compared to expectations based on chance. Here, we examined the consequences of single infection versus coinfection with two common HFS exhibiting variable enrichment, the antiparasitoid Hamiltonella defensa and the antipathogen Regiella insecticola, across three host genotypes and environments. As expected, single infections with either H. defensa or R. insecticola raised defenses against their respective targets. Single infections with protective H. defensa lowered aphid fitness in the absence of enemy challenge, while R. insecticola was comparatively benign. However, as a coinfection, R. insecticola ameliorated H. defensa infection costs. Coinfected aphids continued to receive antiparasitoid protection from H. defensa, but protection was weakened by R. insecticola in two clones. Notably, H. defensa eliminated survival benefits conferred after pathogen exposure by coinfecting R. insecticola Since pathogen sporulation was suppressed by R. insecticola in coinfected aphids, the poor performance likely stemmed from H. defensa-imposed costs rather than weakened defenses. Our results reveal a complex set of coinfection outcomes which may partially explain natural infection patterns and suggest that symbiont-based phenotypes may not be easily predicted based solely on infection status.IMPORTANCE The hyperdiverse arthropods often harbor maternally transmitted bacteria that protect against natural enemies. In many species, low-diversity communities of heritable symbionts are common, providing opportunities for cooperation and conflict among symbionts, which can impact the defensive services rendered. Using the pea aphid, a model for defensive symbiosis, we show that coinfections with two common defensive symbionts, the antipathogen Regiella and the antiparasite Hamiltonella, produce outcomes that are highly variable compared to single infections, which consistently protect against designated enemies. Compared to single infections, coinfections often reduced defensive services during enemy challenge yet improved aphid fitness in the absence of enemies. Thus, infection with multiple symbionts does not necessarily create generalist aphids with "Swiss army knife" defenses against numerous enemies. Instead, particular combinations of symbionts may be favored for a variety of reasons, including their abilities to lessen the costs of other defensive symbionts when enemies are not present.


Subject(s)
Aphids/microbiology , Enterobacteriaceae/physiology , Symbiosis , Animals , Aphids/genetics , Aphids/parasitology , Environment , Genotype
3.
Can J Psychiatry ; 63(5): 338-341, 2018 05.
Article in English | MEDLINE | ID: mdl-29668328

ABSTRACT

This position paper has been substantially revised by the Canadian Psychiatric Association's Research Committee and approved for republication by the CPA's Board of Directors on March 31, 2017. The original position paper1 was developed by the Scientific and Research Council and approved by the Board of Directors on October 4, 1996.


Subject(s)
Clinical Trials as Topic/ethics , Mental Disorders/drug therapy , Placebos , Psychiatry/ethics , Psychotropic Drugs , Research Design , Societies, Medical/ethics , Canada , Humans
4.
Mucosal Immunol ; 9(3): 669-76, 2016 05.
Article in English | MEDLINE | ID: mdl-26376365

ABSTRACT

Secretory leukocyte protease inhibitor (SLPI) is an important respiratory tract host defense protein, which is proteolytically inactivated by excessive neutrophil elastase (NE) during chronic Pseudomonas infection in the cystic fibrosis (CF) lung. We generated two putative NE-resistant variants of SLPI by site-directed mutagenesis, SLPI-A16G and SLPI-S15G-A16G, with a view to improving SLPI's proteolytic stability. Both variants showed enhanced resistance to degradation in the presence of excess NE as well as CF patient sputum compared with SLPI-wild type (SLPI-WT). The ability of both variants to bind bacterial lipopolysaccharides and interact with nuclear factor-κB DNA binding sites was also preserved. Finally, we demonstrate increased anti-inflammatory activity of the SLPI-A16G protein compared with SLPI-WT in a murine model of pulmonary Pseudomonas infection. This study demonstrates the increased stability of these SLPI variants compared with SLPI-WT and their therapeutic potential as a putative anti-inflammatory treatment for CF lung disease.


Subject(s)
Cystic Fibrosis/immunology , Leukocyte Elastase/metabolism , Lung/immunology , Pseudomonas Infections/immunology , Pseudomonas aeruginosa/immunology , Secretory Leukocyte Peptidase Inhibitor/metabolism , Animals , Cells, Cultured , Chronic Disease , Cystic Fibrosis/complications , Disease Models, Animal , Humans , Immunity, Innate , Lung/microbiology , Mice , Mice, Inbred C57BL , Mutagenesis, Site-Directed , Mutation/genetics , Neutrophil Infiltration , Proteolysis , Pseudomonas Infections/complications , Secretory Leukocyte Peptidase Inhibitor/genetics
5.
Mucosal Immunol ; 8(1): 161-75, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25005357

ABSTRACT

The role of proteases in viral infection of the lung is poorly understood. Thus, we examined matrix metalloproteinases (MMPs) and cathepsin proteases in respiratory syncytial virus (RSV)-infected mouse lungs. RSV-induced gene expression for MMPs -2, -3, -7, -8, -9, -10, -12, -13, -14, -16, -17, -19, -20, -25, -27, and -28 and cathepsins B, C, E, G, H, K, L1, S, W, and Z in the airways of Friend leukemia virus B sensitive strain mice. Increased proteases were present in the bronchoalveolar lavage fluid (BALF) and lung tissue during infection. Mitochondrial antiviral-signaling protein (MAVS) and TIR-domain-containing adapter-inducing interferon-ß-deficient mice were exposed to RSV. Mavs-deficient mice had significantly lower expression of airway MMP-2, -3, -7, -8, -9, -10, -12, -13, and -28 and cathepsins C, G, K, S, W, and Z. In lung epithelial cells, retinoic acid-inducible gene-1 (RIG-I) was identified as the major RIG-I-like receptor required for RSV-induced protease expression via MAVS. Overexpression of RIG-I or treatment with interferon-ß in these cells induced MMP and cathepsin gene and protein expression. The significance of RIG-1 protease induction was demonstrated by the fact that inhibiting proteases with batimastat, E64 or ribavirin prevented airway hyperresponsiveness and enhanced viral clearance in RSV-infected mice.


Subject(s)
Adaptor Proteins, Signal Transducing/metabolism , Adaptor Proteins, Vesicular Transport/metabolism , Cathepsins/metabolism , DEAD-box RNA Helicases/physiology , Lung/enzymology , Matrix Metalloproteinases/metabolism , Respiratory Syncytial Virus Infections/immunology , Respiratory Syncytial Viruses/immunology , Adaptor Proteins, Signal Transducing/genetics , Adaptor Proteins, Vesicular Transport/genetics , Animals , DEAD Box Protein 58 , DEAD-box RNA Helicases/genetics , Gene Expression Regulation, Viral , Interferon Type I/immunology , Leucine/administration & dosage , Leucine/analogs & derivatives , Lung/virology , Mice , Mice, Inbred Strains , Mice, Knockout , Phenylalanine/administration & dosage , Phenylalanine/analogs & derivatives , Respiratory Syncytial Virus Infections/drug therapy , Respiratory Syncytial Viruses/drug effects , Ribavirin/administration & dosage , Thiophenes/administration & dosage , Viral Load/drug effects
6.
Br J Surg ; 100(13): 1677-88, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24227352

ABSTRACT

BACKGROUND: Communication is extremely important to ensure safe and effective clinical practice. A systematic literature review of observational studies addressing communication in the operating theatre was conducted. The focus was on observational studies alone in order to gain an understanding of actual communication practices, rather than what was reported through recollections and interviews. METHODS: A systematic review of the literature for accessible published and grey literature was performed in July 2012. The following information was extracted: year, country, objectives, methods, study design, sample size, healthcare professional focus and main findings. Quality appraisal was conducted using the Critical Appraisal Skills Programme. A meta-ethnographic approach was used to categorize further the main findings under key concepts. RESULTS: Some 1174 citations were retrieved through an electronic database search, reference lists and known literature. Of these, 26 were included for review after application of full-text inclusion and exclusion criteria. The overall quality of the studies was rated as average to good, with 77 per cent of the methodological quality assessment criteria being met. Six key concepts were identified: signs of effective communication, signs of communication problems, effects on teamwork, conditions for communication, effects on patient safety and understanding collaborative work. CONCLUSION: Communication was shown to affect operating theatre practices in all of the studies reviewed. Further detailed observational research is needed to gain a better understanding of how to improve the working environment and patient safety in theatre.


Subject(s)
Communication , General Surgery/standards , Operating Rooms , Clinical Competence/standards , Cooperative Behavior , Group Processes , Humans , Interprofessional Relations , Observational Studies as Topic , Patient Care Team/organization & administration , Patient Care Team/standards , Patient Safety , Prospective Studies
7.
Proc Biol Sci ; 280(1751): 20122103, 2013 Jan 22.
Article in English | MEDLINE | ID: mdl-23193123

ABSTRACT

Terrestrial arthropods are often infected with heritable bacterial symbionts, which may themselves be infected by bacteriophages. However, what role, if any, bacteriophages play in the regulation and maintenance of insect-bacteria symbioses is largely unknown. Infection of the aphid Acyrthosiphon pisum by the bacterial symbiont Hamiltonella defensa confers protection against parasitoid wasps, but only when H. defensa is itself infected by the phage A. pisum secondary endosymbiont (APSE). Here, we use a controlled genetic background and correlation-based assays to show that loss of APSE is associated with up to sevenfold increases in the intra-aphid abundance of H. defensa. APSE loss is also associated with severe deleterious effects on aphid fitness: aphids infected with H. defensa lacking APSE have a significantly delayed onset of reproduction, lower weight at adulthood and half as many total offspring as aphids infected with phage-harbouring H. defensa, indicating that phage loss can rapidly lead to the breakdown of the defensive symbiosis. Our results overall indicate that bacteriophages play critical roles in both aphid defence and the maintenance of heritable symbiosis.


Subject(s)
Aphids/microbiology , Enterobacteriaceae/virology , Genetic Fitness/genetics , Podoviridae , Symbiosis , Analysis of Variance , Animals , Aphids/physiology , DNA Primers/genetics , Population Dynamics , Reproduction/physiology , Vicia faba , Viral Proteins/genetics , Viral Proteins/metabolism
8.
Hernia ; 15(2): 225-7, 2011 Apr.
Article in English | MEDLINE | ID: mdl-20165969

ABSTRACT

INTRODUCTION: Laparoscopic techniques for the repair of inguinal hernias have become an increasingly popular alternative to open techniques. No clear consensus has emerged as to the best laparoscopic technique, but the body of evidence increasingly favors a total extraperitoneal (TEP) approach. RESULTS AND DISCUSSION: We report the case of an adult man with an incarcerated right indirect inguinal sliding hernia involving the first known instance of a retroperitoneal ileum, and the novel use of a laparoscopic combined TEP approach and transabdominal preperitoneal (TAPP) approach to repair his hernia without complications. The literature is reviewed and TEP and TAPP techniques for the treatment of inguinal hernias are discussed and compared. CONCLUSION: When faced with an unforeseen anomaly during herniorrhaphy in which improved abdominal visualization is necessary, a surgeon may convert from a TEP to a transabdominal laparoscopic approach safely and effectively.


Subject(s)
Hernia, Inguinal/surgery , Ileum/abnormalities , Ileum/surgery , Laparoscopy/methods , Aged , Humans , Male , Retroperitoneal Space/surgery , Surgical Mesh
9.
Biochem Soc Trans ; 35(Pt 2): 273-6, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17371258

ABSTRACT

Chronic lung disease is one of the most common causes of death and disability worldwide. This group of diseases is characterized by a protease burden, an infective process and a dominant pro-inflammatory profile. While SLPI (secretory leucoprotease inhibitor) was initially identified as a serine protease inhibitor, it has since been shown that SLPI possesses other properties distinct from those associated with its antiprotease capabilities that play an important role in protecting the host from infection and injury. In the course of this review, we will highlight the findings from a range of studies that illustrate the multiple functions of SLPI and its role in the resolution of the immune response.


Subject(s)
Anti-Inflammatory Agents , Cystic Fibrosis/physiopathology , Inflammation/physiopathology , Pulmonary Disease, Chronic Obstructive/physiopathology , Secretory Leukocyte Peptidase Inhibitor/physiology , Anti-Infective Agents , Cystic Fibrosis/prevention & control , Humans , Leukocyte Elastase/metabolism , Protease Inhibitors , Pulmonary Disease, Chronic Obstructive/prevention & control , Secretory Leukocyte Peptidase Inhibitor/chemistry , Secretory Leukocyte Peptidase Inhibitor/immunology
10.
Man Ther ; 8(3): 141-50, 2003 Aug.
Article in English | MEDLINE | ID: mdl-12909434

ABSTRACT

The objective of this study was to conduct a systematic analysis of the literature to assess the efficacy of stretching for prevention of exercise-related injury. Randomized clinical trials (RCTs) and controlled clinical trials (CCTs) investigating stretching as an injury prevention measure were selected. A computer-aided search of the literature was conducted for relevant articles, followed by assessment of the methods of the studies. The main outcome measures were scores for methodological quality based on four main categories (study population, interventions, measurement of effect, and data presentation and analysis) and main conclusions of authors with regard to stretching. One RCT (25%) and three CCTs (100%) concluded that stretching reduced the incidence of exercise-related injury. Three RCTs (75%) concluded that stretching did not reduce the incidence of exercise-related injury. Only two studies scored more than 50 points (maximum score=100 points) indicating that most of the studies selected were of poor quality. Neither of the two highest scoring RCTs showed positive effects for stretching. Due to the paucity, heterogeneity and poor quality of the available studies no definitive conclusions can be drawn as to the value of stretching for reducing the risk of exercise-related injury.


Subject(s)
Athletic Injuries/complications , Exercise , Pain/etiology , Pain/prevention & control , Range of Motion, Articular , Athletic Injuries/physiopathology , Controlled Clinical Trials as Topic , Humans , Isotonic Contraction , Pain/physiopathology , Randomized Controlled Trials as Topic , Research Design/standards , Treatment Outcome
11.
Biochemistry ; 38(36): 11597-603, 1999 Sep 07.
Article in English | MEDLINE | ID: mdl-10512614

ABSTRACT

Inhibition of dipeptidyl peptidase IV (DPP-IV) has been proposed recently as a therapeutic approach to the treatment of type 2 diabetes. N-Substituted-glycyl-2-cyanopyrrolidide compounds, typified by NVP-DPP728 (1-[[[2-[(5-cyanopyridin-2-yl)amino]ethyl]amino]acetyl]-2-cyano-(S )-p yrrolidine), inhibit degradation of glucagon-like peptide-1 (GLP-1) and thereby potentiate insulin release in response to glucose-containing meals. In the present study NVP-DPP728 was found to inhibit human DPP-IV amidolytic activity with a K(i) of 11 nM, a k(on) value of 1.3 x 10(5) M(-)(1) s(-)(1), and a k(off) of 1.3 x 10(-)(3) s(-)(1). Purified bovine kidney DPP-IV bound 1 mol/mol [(14)C]-NVP-DPP728 with high affinity (12 nM K(d)). The dissociation constant, k(off), was 1.0 x 10(-)(3) and 1.6 x 10(-)(3) s(-)(1) in the presence of 0 and 200 microM H-Gly-Pro-AMC, respectively (dissociation t(1/2) approximately 10 min). Through kinetic evaluation of DPP-IV inhibition by the D-antipode, des-cyano, and amide analogues of NVP-DPP728, it was determined that the nitrile functionality at the 2-pyrrolidine position is required, in the L-configuration, for maximal activity (K(i) of 11 nM vs K(i) values of 5.6 to >300 microM for the other analogues tested). Surprisingly, it was found that the D-antipode, despite being approximately 500-fold less potent than NVP-DPP728, displayed identical dissociation kinetics (k(off) of 1.5 x 10(-)(3) s(-)(1)). NVP-DPP728 inhibited DPP-IV in a manner consistent with a two-step inhibition mechanism. Taken together, these data suggest that NVP-DPP728 inhibits DPP-IV through formation of a novel, reversible, nitrile-dependent complex with transition state characteristics.


Subject(s)
Nitriles/pharmacology , Protease Inhibitors/pharmacology , Pyrrolidines/pharmacology , Animals , Caco-2 Cells , Cattle , Dipeptidyl Peptidase 4 , Drug Stability , Humans , Nitriles/chemistry , Nitriles/pharmacokinetics , Protease Inhibitors/chemistry , Protease Inhibitors/pharmacokinetics , Pyrrolidines/chemistry , Pyrrolidines/pharmacokinetics
12.
J Pharmacol Exp Ther ; 272(1): 126-33, 1995 Jan.
Article in English | MEDLINE | ID: mdl-7529307

ABSTRACT

NG-nitro-L-arginine methyl ester (L-NAME) has been reported to have variable effects on the vasodilator response to acetylcholine (ACh) and bradykinin (BK) in vivo. Whether administration of L-NAME affects mean arterial pressure (MAP) or heart rate (HR) responses to ACh or BK was examined in conscious cynomolgus primates. ACh (0.1-10 micrograms/kg i.v.) lowered MAP by 6% to 37%, responses which were inhibited (25-62%) in the presence of L-NAME (1-100 mg/kg i.v.). Although L-NAME increased MAP similarly at doses of 10 and 100 mg/kg, only the 100-mg/kg dose inhibited the hypotensive responses induced by the higher doses of ACh. By comparison, nitroprusside (5 micrograms/kg i.v.)-induced hypotensive responses were not inhibited by L-NAME. Phenylephrine (20 micrograms kg-1 min-1 i.v.) increased MAP and lowered HR to levels statistically similar to that of L-NAME but did not alter ACh-induced hypotensive responses. ACh dose-dependently decreased HR, both in the absence and presence of L-NAME or phenylephrine. In pentobarbital-anesthetized monkeys, ACh-induced hypotensive responses were inhibited by 75% to 94% in the presence of L-NAME; BK (0.3-1 microgram/kg i.v.) responses were only modestly affected (< or = 50%). Therefore, in conscious primates, L-NAME affects the basal release of nitric oxide (NO) at lower doses than those required to inhibit its release stimulated by ACh. Also, L-NAME does not appear to act as a cholinergic antagonist or affect the functional mechanisms that control baroreflex responses.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Acetylcholine/pharmacology , Arginine/analogs & derivatives , Blood Pressure/drug effects , Bradykinin/pharmacology , Heart Rate/drug effects , Amino Acid Oxidoreductases/antagonists & inhibitors , Animals , Arginine/pharmacology , Dose-Response Relationship, Drug , Macaca fascicularis , NG-Nitroarginine Methyl Ester , Nitric Oxide Synthase , Phenylephrine/pharmacology , Wakefulness
13.
Am J Physiol ; 266(6 Pt 2): H2430-5, 1994 Jun.
Article in English | MEDLINE | ID: mdl-8024004

ABSTRACT

We tested the hypothesis that baroreflex attenuation during sodium depletion is due to increased prostaglandin (PG) levels. We studied baroreflex sensitivity before and after PG synthesis inhibition in conscious cynomolgus monkeys. Arterial pressure and pulse interval (PI) were measured during intravenous infusions of phenylephrine (1-20 micrograms.kg-1.min-1, n = 6) and nitroprusside (1-10 micrograms.kg-1.min-1, n = 7). Infusions were repeated 30 min after indomethacin (Indo, 6 mg/kg iv). The slope (in ms/mmHg) of the mean arterial blood pressure-PI plot was used as an index of baroreflex sensitivity. Plasma renin activity (PRA) was elevated (47.9 +/- 9.7 vs. 8.8 +/- 3.3 ng angiotensin I.ml-1.h-1) after sodium depletion (P < 0.05). Baroreflex sensitivity to hypotension and hypertension was significantly (P < 0.05) attenuated by sodium depletion (3.69 +/- 0.9 vs. 0.9 +/- 0.1 ms/mmHg and 7.38 +/- 0.6 vs. 5.04 +/- 0.9 ms/mmHg, respectively). Indo decreased PRA to 28.6 +/- 5.7 ng angiotensin I.ml-1.h-1 (P < 0.05) in sodium-depleted monkeys and decreased heart rate -21 +/- 3.7 from a baseline of 166 +/- 9.40 beats/min in normal monkeys and -22 +/- 2.9 from a baseline of 191 +/- 7.9 beats/min in low-sodium monkeys (P < 0.05). Indo did not significantly change baroreflex sensitivity in either group. Thus the baroreflex was attenuated in conscious nonhuman primates during sodium depletion; acute PG synthesis blockade did not improve baroreflex sensitivity. Indo decreased heart rate without changing arterial pressure; suggesting that PGs caused a downward resetting of the pressure-heart rate relationship.


Subject(s)
Baroreflex/physiology , Prostaglandins/blood , Sodium/deficiency , Animals , Baroreflex/drug effects , Blood Pressure/drug effects , Diet, Sodium-Restricted , Indomethacin/pharmacology , Macaca fascicularis , Male , Nitroprusside/pharmacology , Phenylephrine/pharmacology , Pulse/drug effects , Renin/antagonists & inhibitors , Renin/blood
14.
Vet Microbiol ; 40(3-4): 283-91, 1994 Jun.
Article in English | MEDLINE | ID: mdl-7941293

ABSTRACT

To identify antigens which may be important for stimulating immunity to pneumonic pasteurellosis, a bovine antiserum to whole P. haemolytica was used to screen a recombinant lambda gt11/P. haemolytica expression library. One of the recombinant bacteriophage clones identified with the bovine antiserum, SW20C, expressed a fusion protein which was also recognized by rabbit antiserum to partially purified P. haemolytica culture supernatant and was found to be immunogenic in guinea pigs. The guinea pig antibody recognized a 100 kDa protein in P. haemolytica cell lysates. Sequence analysis of the cloned DNA from SW20C identified a fragment of 1446 bp with a small open reading frame that was contiguous with the lacZ sequence. The 153 bp P. haemolytica-specific open reading frame encoded a polypeptide of approximately 6 kDa. Homology searches of Genbank and the EMBL data bases revealed no homology of this open reading frame with any other bacterial sequences including P. haemolytica leukotoxin and Ssa1. Evaluation of sera from calves that were scored either susceptible or resistant to experimental pneumonic pasteurellosis demonstrated a significant (P < 0.001) correlation between the intensity of the antibody response to the SW20C antigen and resistance to disease.


Subject(s)
Antigens, Bacterial/isolation & purification , Mannheimia haemolytica/immunology , Pasteurellosis, Pneumonic/immunology , Amino Acid Sequence , Animals , Antigens, Bacterial/chemistry , Antigens, Bacterial/genetics , Base Sequence , Cattle , Immunity, Innate , Molecular Sequence Data , Pasteurellosis, Pneumonic/microbiology , Sequence Analysis, DNA
15.
J Med Chem ; 35(26): 4795-808, 1992 Dec 25.
Article in English | MEDLINE | ID: mdl-1479581

ABSTRACT

A series of tripeptides which contain alpha,alpha-difluorostatone residues at P1-P1' and span the S3-S1' subsites have been shown to be potent inhibitors of human leukocyte elastase (HLE). The tripeptides described contain the nonproteinogenic achiral residue N-(2,3-dihydro-1H-inden-2-yl)glycine at the P2-position. This redidue has previously been shown in the case of HLE to be a good bioisosteric replacement for L-proline. Of the peptides prepared, those which contain the alpha,alpha-difluoromethylene keton derivative of L-valine (difluorostatone) are the preferred residue at the P1-primary specificity position. Substitution at P1 by the corresponding alpha,alpha-difluoromethylene ketones of L-leucine and L-phenylalanine gives inactive compounds. Of the tripeptides described the most potent in vitro compound is ethyl N-[N-CBZ-L-valyl-N-(2,3-dihydro-1H-inden-2-yl)glycyl]- 4(S)-amino-2,2-difluoro-3-oxo-5-methylhexanoate (17B) (IC50 = 0.635 microM). It is presumed that the inhibitor 17b interacts with the S3-S1' binding regions of HLE. Additionally extended binding inhibitors were prepared which interact with the S3-S3' binding subsites of HLE. In order to effect interaction with the S1'-S3' subsites of HLE, the leaving group side of cleaved peptides, spacers based upon Gly-Gly, and those linked via the N epsilon of L-lysine were utilized. One of the most potent extended compounds (P3-P3') in vitro is methyl N6-[4(S)-[[N-[N-CBZ-L-valyl-N- (2,3-dihydro-1H-inden-2-yl)glycyl]amino]-2,2-difluoro-3-oxo-5- methylhexanoyl]-2(S)-(acetylamino)-6-aminohexanoate (24b) (IC50 = 0.057 microM). The described in vitro active inhibitors were also evaluated in hamsters in an elastase-induced pulmonary hemorrhage (EPH) model. In this model, intratracheal (it.) administration of 22c, 5 min prior to HLE challenge (10 micrograms, it.) effectively inhibited hemorrhage (94.6%) in a dose-dependent manner. The described alpha,alpha-difluoromethylene ketone inhibitors are assumed to act as transition-state analogs. The inhibition process presumably acts via hemiketal formation with the active site Ser195 of HLE, and is facilitated by the strongly electron withdrawing effect of the alpha,alpha-difluoromethylene functionality.


Subject(s)
Hydrocarbons, Fluorinated/chemical synthesis , Oligopeptides/chemical synthesis , Pancreatic Elastase/antagonists & inhibitors , Amino Acid Sequence , Animals , Binding Sites/drug effects , Cricetinae , Humans , Hydrocarbons, Fluorinated/chemistry , Hydrocarbons, Fluorinated/pharmacology , Leukocyte Elastase , Male , Mesocricetus , Models, Molecular , Molecular Sequence Data , Oligopeptides/chemistry , Oligopeptides/pharmacology , Structure-Activity Relationship , Turkeys
16.
J Biol Chem ; 265(13): 7308-17, 1990 May 05.
Article in English | MEDLINE | ID: mdl-2110163

ABSTRACT

The amino acid sequence of the mitochondrial form of phosphoenolpyruvate carboxykinase (GTP) (EC 4.1.1.32) (PEPCK-M) from the chicken was deduced from the 3571 nucleotide sequence of three overlapping cDNA clones. The derived protein sequence, which includes 607 amino acids of the mature enzyme and a leader sequence, was aligned with nine tryptic peptides of PEPCK-M and the primary sequence of the cytosolic form of PEPCK from chicken. Secondary structure predictions for the two PEPCK isozymes indicated similar packing elements of conserved, hydrophobic beta strands in the central core of the primary sequence. This core protein, which contained three GTP-binding consensus elements, was 80% identical in the two chicken isozymes, although the overall level of identity was only 63% for amino acids and 60% for nucleotides. The untranslated regions of the two cDNAs were dissimilar, although both mRNAs have potential for significant secondary structure. The PEPCK-M mRNA contained several G-C-rich regions which demonstrated free energies of formation in dyad symmetry programs up to -70 kcal/mol. The 1.6-kilobase (kb) 3'-untranslated region contained several repeat elements including one of 11 base pairs, which was present 30 times; but, a signal sequence for polyadenylation was not present. Each of the three PEPCK-M cDNA clones recognized two mRNAs of 4.2 and 3.4 kb in the livers and kidneys of starved or normally fed chickens. However, the level of these two related PEPCK-M mRNAs changed in response to cAMP treatment, with the larger mRNA predominant at 20 and 160 min and the 3.4-kb mRNA present at intermediate times. In contrast, the level of the 2.8-kb PEPCK-C mRNA increased dramatically upon addition of the cyclic nucleotide, particularly in the liver where it was not detected without cAMP induction. Thus, PEPCK-M and PEPCK-C, clearly represented the products of two distinct genes, which were distinguished by altered protein sequences and non-cross-hybridizing, differentially regulated mRNAs.


Subject(s)
DNA/genetics , Isoenzymes/genetics , Liver/enzymology , Mitochondria, Liver/enzymology , Phosphoenolpyruvate Carboxykinase (GTP)/genetics , Amino Acid Sequence , Animals , Base Sequence , Blotting, Northern , Chickens , Cytosol/enzymology , GTP-Binding Proteins/metabolism , Gene Library , Isoenzymes/metabolism , Molecular Sequence Data , Oligonucleotide Probes , Peptide Fragments/isolation & purification , Phosphoenolpyruvate Carboxykinase (GTP)/metabolism , RNA, Messenger/genetics , Restriction Mapping , Sequence Homology, Nucleic Acid
17.
J Virol ; 64(3): 1357-9, 1990 Mar.
Article in English | MEDLINE | ID: mdl-2154614

ABSTRACT

Translation of in vitro-synthesized herpes simplex virus type 2 (HSV-2) gG-2 mRNA in a reticulocyte lysate system was used to study the processing of HSV-2 gG-2. In the presence of canine pancreatic microsomal membranes, a single species that is protected from trypsin digestion was detected. This product comigrates with the 104,000-Mr (104K) high mannose intermediate seen in HSV-2-infected-cell lysates. Endo-beta-N-acetylglucosaminidase H treatment of the in vitro-synthesized 104K protein yielded a single product migrating at 100 K. The 72K and 31K cleavage products of gG-2 were not observed in the in vitro system. These data show that the molecular weight of the nonglycosylated form of the gG-2 protein is 100,000 and that the cotranslational processing of this protein in the endoplasmic reticulum yields the 104K high-mannose intermediate.


Subject(s)
Protein Biosynthesis , RNA, Messenger/genetics , Simplexvirus/genetics , Transcription, Genetic , Viral Envelope Proteins/genetics , Animals , Cell Line , Cell-Free System , Genetic Vectors , Glycosylation , Humans , Molecular Weight , Reticulocytes/metabolism , Viral Envelope Proteins/biosynthesis
18.
J Biol Chem ; 263(27): 13641-54, 1988 Sep 25.
Article in English | MEDLINE | ID: mdl-2843526

ABSTRACT

The site and mechanism of dioxygen reduction in cytochrome c oxidase from bovine heart muscle have been investigated. The rate of cytochrome c2+ oxidation by O2 is shown to be affected by several factors: 1) pH, with optima at 5.65 and 6.0, 2) temperature between 0 and 29 degrees C, with E alpha = 13 kcal mol-1, 3) D2O exchange, with a reduction in rate of 50% or more at the pH optima, and 4) the addition of ethylene glycol or glycerol, which significantly lowers the rate. The extremely narrow (delta vCO approximately 4 cm-1) infrared stretch bands at approximately 1964 and approximately 1959 cm-1 for liganded CO are only slightly affected by factors 1-4 or by changes in the oxidation state of metals other than the heme alpha 3 iron. These results indicate a stable, unusually immobile O2 reduction site well-isolated from the external medium, a characteristic expected to be important for oxidase function. Precise stereochemical positioning of hydrogen donors adjacent to O2 liganded to heme alpha 3 iron can be expected in order to achieve the optimization of the time/distance relationships required for enzyme catalysis. These findings support a novel mechanism of O2 reduction via a hydroperoxide intermediate within a reaction pocket that experiences little change in conformation during the hydrogen and electron transfer steps.


Subject(s)
Electron Transport Complex IV/metabolism , Myocardium/enzymology , Oxygen/metabolism , Animals , Carbon Monoxide/metabolism , Cattle , Ethylene Glycol , Ethylene Glycols/pharmacology , Glycerol/pharmacology , Hydrogen-Ion Concentration , Kinetics , Oxidation-Reduction , Solvents , Spectrophotometry, Infrared , Temperature , Thermodynamics
19.
Proc Natl Acad Sci U S A ; 83(20): 7583-7, 1986 Oct.
Article in English | MEDLINE | ID: mdl-3094011

ABSTRACT

We have determined the sequence of the mRNA encoding cytosolic phosphoenolpyruvate carboxykinase (GTP) [GTP:oxaloacetate carboxy-lyase (transphosphorylating), EC 4.1.1.32] from the chicken and have deduced the primary structure of the protein. The message for the enzyme is 2762 bases long and encodes a protein of 622 amino acids with a molecular mass of 69,522 daltons. The 5' untranslated region is 246 nucleotides long and contains two nonfunctional AUG initiator codons. The 3' untranslated sequence is 649 bases long and contains multiple polyadenylylation signals. There are regions of dyad symmetry and an A + U-rich region within the 3' translated and untranslated sequences of the message. Such regions are also present in the mRNA for the enzyme from the rat and may be of functional significance. Conserved regions of the enzyme, that may interact with substrates, were identified by comparing the amino acid sequence of phosphoenolpyruvate carboxykinase with that of other proteins that use guanine nucleotides and phosphoenolpyruvate as substrates.


Subject(s)
Cytosol/enzymology , Phosphoenolpyruvate Carboxykinase (GTP)/genetics , RNA, Messenger/analysis , Amino Acid Sequence , Animals , Base Sequence , Chickens , GTP-Binding Proteins/analysis , Phosphoenolpyruvate Carboxykinase (GTP)/analysis , Protein Conformation
SELECTION OF CITATIONS
SEARCH DETAIL